Related Experiment Video
Updated: Aug 4, 2026
10:01
Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
Published on: July 10, 2012
Pulmonary infections after bone marrow transplant
1Bone Marrow Transplantation Program, Indiana University Hospitals, Indianapolis.
Seminars in Respiratory Infections
|June 1, 1992
Summary
Pneumonia is a major risk after bone marrow transplant, often caused by fungi or cytomegalovirus within 3 months. Prophylactic therapies are crucial for preventing these life-threatening pulmonary complications.
Area of Science:
- Hematology
- Infectious Diseases
- Pulmonology
Background:
- Pneumonia affects up to 50% of bone marrow transplant recipients, representing a leading cause of mortality.
- Patients face increased pulmonary complication risk due to pre-transplant treatments, conditioning regimens, graft-versus-host disease prophylaxis, and prolonged immunosuppression.
Purpose of the Study:
- To review the common causes and timing of pneumonia following bone marrow transplantation.
- To highlight the significance of early and late-onset pneumonias and their respective etiologies.
- To emphasize the importance of prophylactic strategies in managing post-transplant pulmonary complications.
Main Methods:
- Review of existing literature on pneumonia post-bone marrow transplant.
- Analysis of common infectious and non-infectious etiologies.
- Discussion of treatment outcomes for specific infections like cytomegalovirus.
Main Results:
- The highest risk period for pneumonia is within 3 months post-transplant, with fungal and cytomegalovirus infections being most common.
- Idiopathic interstitial pneumonia in this period may indicate treatment toxicity.
- Late bacterial pneumonia (>6 months) is linked to prolonged immunodeficiency and functional asplenia.
Conclusions:
- Cytomegalovirus pneumonia treatment has improved with ganciclovir and immunoglobulin.
- Effective prophylactic therapies are essential components of bone marrow transplant patient care.
- Addressing both infectious and non-infectious causes is critical for reducing pneumonia-related mortality.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...